FWF-Funded project (KLI 1036)

Understanding Fontan Biology

A molecular and cellular perspective on cardiovascular research

Medical University of Innsbruck, Austria

Our Vision

Fontan circulation creates both physiological and metabolic challenges. Fontanomics investigates these abnormalities at molecular level to develop targeted therapies that improve patient lives.

Molecular
Advanced metabolomics and
proteomics analysis
Physiological
Understanding circulation patterns
Prognostic
Biomarker development for risk stratification
Therapeutic
Novel targeted treatment approaches

Research Focus Areas

Our interconnected research topics advancing our understanding of Fontan circulation

Topic 1: Molecular Foundations

Reimagining the fundamentals – "Coming back to the blackboard"
Hypothesis

A return to basic physiology and biochemistry is key to address the unique challenges in Fontan circulation.

Primary aim

To develop mechanistic approaches to comprehend altered core biological processes in patients with a Fontan circulation.

Secondary aims

To reveal links between small molecule analytes on biochemistry basis, on transcriptomic and genomic basis that regulates Fontan circulation.

Topic 2: The Fontan Radar

Harnessing the power of advanced Biomarkers and Omics
Hypothesis

Omics technologies are medical revolution. They are key to unraveling the complex origins and interconnections of Fontan-related comorbidities.

Primary aim

We are also exploring the full potential of existing biomarkers, whether they are published in literature on Fontan circulation and general cardiology.

Secondary aims

To develop an accurate prognosis: By strategically employing biomarkers, we aim to improve diagnostics, monitor risk stratification, and outcome prediction.

Topic 3: Cardiac Metabolism

Metabolism: a major factor determining outcomes in Fontan?
Hypothesis

Metabolic and regulatory processes, including energy metabolism, oxidative stress, inflammation, immunity, and endothelial function are determining Fontan outcomes.

Aim

We are integrating hemodynamic and metabolic evaluations to create a comprehensive picture of Fontan pathophysiology.

Topic 4: Targeted Metabolic Therapies

Expanding treatment options to live a full life with half a heart.
Method

Our research group intends advancing clinical trials focused on metabolic interventions for selected subgroups of patients with a Fontan circulation.

Aim

To develop a comprehensive approach that extends from established palliative medical therapy to a targeted metabolic therapy for improved quality of life.